In newly diagnosed patients not yet undergoing immunosuppressive therapy, MPA-MONO (3 patients) and MPA-IFN (8 patients) remained distinctly classified (Supplementary Fig. 12a). This evidence concerns the gene IFNA1 and microscopic polyangiitis.